SECTION 1. IDENTIFICATION
Product Name: Lithium Nickel Dioxide
CAS #: 12031-65-1
Relevant identified uses of the substance: Scientific research and development
Supplier details:
Stanford Advanced Materials
E-mail: sales@samaterials.com
Tel: (949) 407-8904
Address: 23661 Birtcher Dr., Lake Forest, CA 92630 U.S.A.
SECTION 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Skin sensitisation(Category 1), H317
Carcinogenicity(Category 2), H351
GHS Label elements, including precautionary statements
Pictogram
Signal word
Warning
Hazard statement(s)
H317
May cause an allergic skin reaction.
H351
Suspected of causing cancer.
Precautionary statement(s)
P201Obtain special instructions before use.
P202
Do not handle until all safety precautions have been read and understood.
P261
Avoid breathing dust/ fume/ gas/ mist/ Vapors/ spray.
P272
Contaminated work clothing should not be allowed out of the workplace.
P280
Wear protective gloves.
P302 + P352
IF ON SKIN: Wash with plenty of soap and water.
P308 + P313
IF exposed or concerned: Get medical advice/ attention.
P321
Specific treatment (see supplemental first aid instructions on this label).
P333 + P313
If skin irritation or rash occurs: Get medical advice/ attention.
P363
Wash contaminated clothing before reuse.
P405
Store locked up.
P501
Dispose of contents/ container to an approved waste disposal plant.
Hazards not otherwise classified (HNOC) or not covered by GHS-none
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms: Lithium nickel oxide, Lithium nickelate, LNO
Formula: LiNiO2
Molecular weight: 97.63 g/mol
CAS-No.: 12031-65-1
Index-No.: 028-057-00-7
SECTION 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a
physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2) and/orin section 11
Indication of any immediate medical attention and special treatment needed
no data available
SECTION 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
no data available
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available
SECTION 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.
SECTION 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation o
f dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.
Conditions for safe storage, including any incompatibilities
Ke
ep container tightly closed in a dry and well
-
ventilated place.
Keep in a dry place.
7.3
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated
SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Contains no substances with occupational exposure limit values.
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks
and at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such as
NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form: powder
Colour: black
Odor
odourless
Odor Threshold
No data available
pH
No data available
Melting point/freezing point
Melting point/range: > 1,000 °C (> 1,832 °F)
Initial boiling point and boiling range
No data available
Flash point
No data available
Evaporation rate
No data available
Flammability (solid, gas)
No data available
Upper/lower flammability or explosive limits
No data availableVapor pressure
No data available
Vapor density
No data available
Relative density
No data available
Water solubility
No data available
Partition coefficient: n-octanol/water
No data available
Auto-ignition temperature
No data available
Decomposition temperature
No data available
Viscosity
No data available
Explosive properties
No data available
Oxidizing properties
No data available
Other safety information
No data available
SECTION 10. STABILITY AND REACTIVITY
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions.-Nickel/nickel oxides, Lithium oxides
Other decomposition products-No data available
In the event of fire: see section 5
SECTION 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritationNo data available
Respiratory or skin sensitisation
Germ cell mutagenicity
No data available
Carcinogenicity
Human carcinogen.
IARC:
1-Group 1: Carcinogenic to humans(lithium nickel dioxide)
IARC:
1-Group 1: Carcinogenic to humans(lithium nickel dioxide)
NTP:
Known to be human carcinogen(lithium nickel dioxide)
NTP:
Known to be human carcinogen(lithium nickel dioxide)
OSHA:
No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
No data available
Specific target organ toxicity -single exposure
No data available
Specific target organ toxicity -repeated exposure
Causes damage to organs through prolonged or repeated exposure.
Aspiration hazard
No data available
Additional Information
RTECS: Not available
Lithium and its compounds are possible teratogens by analogy to lithium carbonate which has
equivocal human teratogenic data and positive animal teratogenic data., Large doses of lithium ion
have caused dizziness and prostration, and can cause kidney damage if sodium intake is limited.
Dehydration, weight loss, dermatological effects, and thyroid disturbances have been reported. Central
nervous system effects that include slurred speech, blurred vision, sensory loss, ataxia, and
convulsions may occur. Diarrhea, vomiting, and neuromuscular effects such as tremor, clonus, and
hyperactive reflexes may occur as a result of repeated exposure to lithium ion., To the best of our
knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Stomach-Irregularities-Based on Human Evidence
Stomach-Irregularities-Based on Human Evidence
SECTION 12. ECOLOGICAL INFORMATION
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conductedOther adverse effects
No data available
SECTION 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contact a licensed professional waste disposal service to dispose of this material.
Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped
with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.
SECTION 14. TRANSPORT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
SECTION 15. REGULATORY INFORMATION
SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
The following components are subject to reporting levels established by SARA Title III, Section 313:
lithium nickel dioxide
CAS-No.
12031-65-1
Revision Date
2007-07-01
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
lithium nickel dioxide
CAS-No.
12031-65-1
Revision Date
2007-07-01
New Jersey Right To Know Components
lithium nickel dioxide
CAS-No.
12031-65-1
Revision Date
2007-07-01California Prop. 65 Components
WARNING! This product contains a chemical known to the State of California to cause cancer.
lithium nickel dioxide
CAS-No.
12031-65-1
Revision Date
2007-09-28
WARNING! This product contains a chemical known to the State of California to cause cancer.
lithium nickel dioxide
CAS-No.
12031-65-1
Revision Date
2007-09-28
SECTION 16. OTHER INFORMATION
Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH). The above information is
believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The
information in this document is based on the present state of our knowledge and is applicable to the
product with regard to appropriate safety precautions. It does not represent any guarantee of the
properties of the product.
